News

The U.S. Food and Drug Administration declined to approve Capricor Therapeutics' cell therapy for a heart condition and asked ...
Capricor Therapeutics said on Friday the U.S. Food and Drug Administration has declined to approve its cell therapy ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising questions about whether the agency's new leadership may be rowing back from ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
“We want to focus on food. People forget that the ‘F’ in FDA stands for food,” Makary said. Makary noted that the processed ...
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment ...
Joe Lonsdale, co-founder of the large government contractor Palantir, wants to embed a team of 15 to 20 “elite engineers” ...
The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...